Is There a Balance Between Regulation and Policy in the Face of Accelerated Innovation?

You had front row seat to the production and roll out of covo 19 vaccine. How do you think we should balance regulation and policy in the face of this sort of accelerating innovation that we're seeing? Do we get the balance right? No. There's people on both sides of this debate. People who are saying, you know, the fta is too lax, and people who the eptas too strict. And thereis all these promising drugs that aren't becoming available to patients wo face life threatening disorders.